Medical oncologist Dr. Luis Paz-Ares MD, Ph.D joins Leadartis´ scientific advisory board

10-12-2018

Luis Paz-Ares MD, PhD. Chair of the Medical Oncology Department at the Hospital 12 de Octubre, Associate, Professor at the Universidad Complutense and Head of the Lung Cancer Unit at the CNIO (National Oncology Research Center) in Madrid, Spain recently has joined Leadartis´ scientific advisory board. He graduated in Medicine and completed his PhD at the Universidad Autonoma Madrid (UAM). He was a postdoctoral ESMO Research Fellow in Medical Oncology at the Beatson Oncology Centre, University of Glasgow, Scotland; chair of the Medical Oncology Department at the Virgen del Rocío University Hospital in Seville, Head of the early clinical studies at the 12 de Octubre and Visiting Research Fellow at the Dana-Farber Cancer Institute in Boston, USA. Luis’s research focuses on lung cancer and new therapeutics; he has published over 200 articles in peer review journals, served as a member of several committees, including ASCO, ESMO, European Organisation of Cancer Protocol Review & the Spanish European Medicines Agency.

Latest News

Leadartis discloses the project: ATTACK-Cancer immunotherapy by bispecific antibodies that recruit T lymphocytes
11-12-2018

LeadArtis is pleased to announce its participation as coordinator of the ATTACK project (Cancer...

Medical oncologist Dr. Luis Paz-Ares MD, Ph.D joins Leadartis´ scientific advisory board
10-12-2018

Luis Paz-Ares MD, PhD. Chair of the Medical Oncology Department at the Hospital 12 de Octubre,...

Nature Communications: LeadArtis outlines a new bispecific antibody that could hold the key to activate cancer killer T-cells to find and destroy highly prevalent tumors
17-11-2018

LeadArtis and collaborators have published in the highly regarded scientific journal Nature...